LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom relief with no adverse effect on sexual function, long-term results from ...
A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable improvement in urinary symptoms and flow rate, according to data from three ...
Taken together, long-term data from a pivotal sham-controlled trial and a single-arm study demonstrate Optilume BPH’s durable efficacy over at least 3 years. The Optilume® benign prostatic hyperplasia ...
BPH prostate treatment market is evolving toward a more patient-focused, technology-driven ecosystem. As innovation in both pharmaceuticals and minimally invasive procedures accelerates, companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results